BMT/SCT News http://www.mdlinx.com/HemeOncLinx/news.cfm/newspage/1/spec_id/17/subspec_id/589 BMT/SCT en-us Copyright 2009 MDLinx, Inc. <![CDATA[Consolidation with high-dose chemotherapy and stem cell support for responding patients with metastatic soft tissue sarcomas: prospective, single-institutional phase II study]]> http://www.mdlinx.com/HemeOncLinx/xml-article.cfm/2961455 11/25/2009 Bone Marrow Transplantation]]> http://www.mdlinx.com/HemeOncLinx/xml-article.cfm/2961455 <![CDATA[Health-related quality of life following haematopoietic cell transplantation: patient education, evaluation and intervention]]> http://www.mdlinx.com/HemeOncLinx/xml-article.cfm/2954928 11/25/2009 British Journal of Haematology]]> http://www.mdlinx.com/HemeOncLinx/xml-article.cfm/2954928 <![CDATA[Cord blood and bone marrow transplantation in inherited metabolic diseases: scientific basis, current status and future directions]]> http://www.mdlinx.com/HemeOncLinx/xml-article.cfm/2954925 11/25/2009 British Journal of Haematology]]> http://www.mdlinx.com/HemeOncLinx/xml-article.cfm/2954925 <![CDATA[Purified T-depleted, CD34+ peripheral blood and bone marrow cell transplantation from haploidentical mother to child with thalassemia]]> http://www.mdlinx.com/HemeOncLinx/xml-article.cfm/2943994 11/25/2009 Blood]]> http://www.mdlinx.com/HemeOncLinx/xml-article.cfm/2943994 <![CDATA[Cord Blood Units with Low CD34+ Cell Viability Have a Low Probability of Engraftment After Double Unit Transplantation]]> http://www.mdlinx.com/HemeOncLinx/xml-article.cfm/2961654 11/25/2009 Biology of Blood and Marrow Transplantation]]> http://www.mdlinx.com/HemeOncLinx/xml-article.cfm/2961654 <![CDATA[Human herpes virus 6 infection is a hallmark of cord blood transplant in adults and may participate to delayed engraftment: a comparison with matched unrelated donors as stem cell source]]> http://www.mdlinx.com/HemeOncLinx/xml-article.cfm/2961454 11/25/2009 Bone Marrow Transplantation]]> http://www.mdlinx.com/HemeOncLinx/xml-article.cfm/2961454 <![CDATA[Functional characterization of alloreactive T-cells identifies CD25 and CD71 as optimal targets for a clinically applicable allodepletion strategy]]> http://www.mdlinx.com/HemeOncLinx/xml-article.cfm/2940974 11/25/2009 Blood]]> http://www.mdlinx.com/HemeOncLinx/xml-article.cfm/2940974